Inventor · disambiguated record
Frank Bennett
Also filed as: BENNETT FRANK · BENNETT FRANK C
51 granted patents·10 pending applications·1,447 citations·filing 1992–2021
99Inventor score
Top patents by PatentIndex Score
61 records- 0197US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0296US7186747B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 6, 2007·47 cites·31 claims
- 0396US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 0495US7592316B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2007·Granted Sep 22, 2009·34 cites·6 claims
- 0595US7425576B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Sep 16, 2008·20 cites·24 claims
- 0695US7205330B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2005·Granted Apr 17, 2007·54 cites·29 claims
- 0795US7173057B2Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virusSCHERING CORP·Filed 2005·Granted Feb 6, 2007·44 cites·29 claims
- 0895US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 0994US9156872B22′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 13, 2015·45 cites·21 claims
- 1094US9061041B22′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Jun 23, 2015·49 cites·43 claims
- 1194US8697694B2Substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsARASAPPAN ASHOK·Filed 2009·Granted Apr 15, 2014·52 cites·7 claims
- 1294US7423058B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2006·Granted Sep 9, 2008·15 cites·22 claims
- 1394US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 1494US5661151ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Aug 26, 1997·69 cites·13 claims
- 1593US7192957B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 20, 2007·28 cites·28 claims
- 1693US6403564B1Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 1999·Granted Jun 11, 2002·122 cites·2 claims
- 1793US6277830B15′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferonSCHERING CORP·Filed 1999·Granted Aug 21, 2001·120 cites·43 claims
- 1892US8541434B2Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsKWONG CECIL D·Filed 2009·Granted Sep 24, 2013·39 cites·17 claims
- 1992US6894072B2Compounds as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2003·Granted May 17, 2005·59 cites·25 claims
- 2090US10221163B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·4 cites·67 claims
- 2189USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 2287US9150603B22′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 6, 2015·14 cites·21 claims
- 2387US5714490ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Feb 3, 1998·37 cites·20 claims
- 2484US5516784AAnti-HIV (AIDS) agentsSCHERING CORP·Filed 1992·Granted May 14, 1996·26 cites·18 claims
- 2583US10544130B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jan 28, 2020·1 cites·20 claims
- 2683US8067379B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseBENNETT FRANK·Filed 2005·Granted Nov 29, 2011·8 cites·43 claims
- 2782US7619094B2Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virusSCHERING CORP·Filed 2006·Granted Nov 17, 2009·5 cites·33 claims
- 2880US9732111B22′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Granted Aug 15, 2017·2 cites·17 claims
- 2980US5693626ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 2, 1997·24 cites·11 claims
- 3079US6924270B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2001·Granted Aug 2, 2005·11 cites·16 claims
- 3177US10227331B2Metallo-β-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Mar 12, 2019·1 cites·26 claims
- 3277US7115578B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2004·Granted Oct 3, 2006·8 cites·7 claims
- 3374US8765700B2Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditionsTACHAS GEORGE·Filed 2005·Granted Jul 1, 2014·2 cites·14 claims
- 3474US6673775B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2001·Granted Jan 6, 2004·4 cites·38 claims
- 3574US5703079ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 30, 1997·16 cites·9 claims
- 3671US8143305B22,3-substituted indole derivatives for treating viral infectionsANILKUMAR GOPINADHAN N·Filed 2008·Granted Mar 27, 2012·2 cites·12 claims
- 3770US5710154ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Jan 20, 1998·13 cites·20 claims
- 3868US9765107B2Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Sep 19, 2017·1 cites·13 claims
- 3964US9433621B2Substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsARASAPPAN ASHOK·Filed 2011·Granted Sep 6, 2016·1 cites·7 claims
- 4062US2011286969A1Deuterated compounds as hepatitis c virus (hcv) inhibitorsMACCOSS MALCOLM·Filed 2009·Application pending·0 cites
- 4158US7718691B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted May 18, 2010·0 cites·33 claims
- 4257US2006205672A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2005·Application pending·0 cites
- 4356US7759499B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Jul 20, 2010·0 cites·22 claims
- 4456US5693815APeptidesSCHERING CORP·Filed 1994·Granted Dec 2, 1997·5 cites·10 claims
- 4555US2024018145A1Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenzaMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 4654US5703236ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 30, 1997·11 cites·4 claims
- 4753US2011117057A1Novel peptides as ns3-serine protease inhibitors of hepatitis c virusSCHERING CORP·Filed 2010·Application pending·0 cites
- 4853US2005059606A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2004·Application pending·0 cites
- 4951US11685761B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2018·Granted Jun 27, 2023·0 cites·20 claims
- 5051US7595299B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2005·Granted Sep 29, 2009·0 cites·5 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Frank Bennett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →